Age distribution, polyps and rectal cancer in the egyptian population-based cancer registry

World Journal of Gastroenterology

Volumn 18, Issue 30, 2012, Pages 3997-4003

  Veruttipong, Darlene ^a   Soliman, Amr S ^a   Gilbert, Samuel F ^a   Blachley, Taylor S ^a   Hablas, Ahmed ^b   Ramadan, Mohamed ^b   Rozek, Laura S ^a   Seifeldin, Ibrahim A ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b Tanta Cancer Center and the Gharbiah Population Based Cancer Registry   (Egypt)

Author keywords

Colorectal cancer; Developing countries; Egypt; Polyps; Young onset

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER REGISTRY; COLLOID CARCINOMA; COLORECTAL CANCER; EGYPT; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POLYP; RECTUM CANCER; RURAL AREA; UNITED STATES; URBAN AREA;

EID: 84871490407     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i30.3997     Document Type: Article

References (38)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, editors. Globocan 2008: Cancer Incidence and Mortality Worldwide. Lyon, France: International Agency for Research on Cancer, 2010
2. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59: 366-378
3. Popkin BM. The nutrition transition in low-income countries: an emerging crisis. Nutr Rev 1994; 52: 285-298
4. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236
5. Soliman AS, Bondy ML, Levin B, Hamza MR, Ismail K, Ismail S, Hammam HM, el-Hattab OH, Kamal SM, Soliman AG, Dorgham LA, McPherson RS, Beasley RP. Colorectal cancer in Egyptian patients under 40 years of age. Int J Cancer 1997; 71: 26-30
6. Soliman AS, Bondy ML, El-Badawy SA, Mokhtar N, Eissa S, Bayoumy S, Seifeldin IA, Houlihan PS, Lukish JR, Watanabe T, Chan AO, Zhu D, Amos CI, Levin B, Hamilton SR. Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients. Br J Cancer 2001; 85: 1037-1046
7. Chan AO, Soliman AS, Zhang Q, Rashid A, Bedeir A, Houlihan PS, Mokhtar N, Al-Masri N, Ozbek U, Yaghan R, Kandilci A, Omar S, Kapran Y, Dizdaroglu F, Bondy ML, Amos CI, Issa JP, Levin B, Hamilton SR. Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries. Clin Cancer Res 2005; 11: 8281-8287
8. Soliman AS, Smith MA, Cooper SP, Ismail K, Khaled H, Ismail S, McPherson RS, Seifeldin IA, Bondy ML. Serum organochlorine pesticide levels in patients with colorectal cancer in Egypt. Arch Environ Health 1997; 52: 409-415
9. Ibrahim AS, Hussein H, Ismail K, Hablas A, Abdel BI, Ramadan M, editors. Gharbiah Population-based Cancer Registry (GPCR): Cancer Profile in Gharbiah-Egypt: Methodology and Results 1999. Cairo, Egypt: Ministry of Health and Populations Egypt and Middle East Cancer Consortium, 2002
10. Central Agency for Public Mobilization and Statistics. Statisical Year Book. Cairo, Egypt: Central Agency of Public Mobilization and Statistics, 2005
11. Freedman LS, Edwards BK, Ries LAG, Young JL, editors. National Cancer Institute (US), Middle East Cancer Consortium. Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the. Middle East Cancer Consortium (MECC) Compared with US SEER. Bethesda, MD: National Cancer Institute, 2006
12. Ibrahim AS. Cancer in the Nile Delta Region: A report from the gharbiah population-based cancer registry 2000-2002. Tanta: Gharbiah Population-Based Cancer Registry, 2007
13. Barchana M. Colorectal cancer. In: Freedman LS, Edwards BK, Ries LAG, Young JL, editors. National Cancer Institute (US), Middle East Cancer Consortium. Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the. Middle East Cancer Consortium (MECC) Compared with US SEER. Bethesda, MD: National Cancer Institute, 2006: 41-45
14. Soliman AS, Bondy ML, Hamilton SR, Levin B. Colon cancer in young Egyptian patients. Am J Gastroenterol 1999; 94: 1114
15. Dey S, Zhang Z, Hablas A, Seifeldein IA, Ramadan M, El-Hamzawy H, Soliman AS. Geographic patterns of cancer in the population-based registry of Egypt: Possible links to environmental exposures. Cancer Epidemiol 2011; 35: 254-264
16. Soliman AS, Bondy ML, Levin B, El-Badawy S, Khaled H, Hablas A, Ismail S, Adly M, Mahgoub KG, McPherson RS, Beasley RP. Familial aggregation of colorectal cancer in Egypt. Int J Cancer 1998; 77: 811-816
17. Soliman AS, Levin B, El-Badawy S, Nasser SS, Raouf AA, Khaled H, El-Hattab OH, Chamberlain RM. Planning cancer prevention strategies based on epidemiologic characteristics: an Egyptian example. Public Health Rev 2001; 29: 1-11
18. Walker M, O'Sullivan B, Perakath B, Taniere P, Cruger D, Morton D. Selecting patients with young-onset colorectal cancer for mismatch repair gene analysis. Br J Surg 2007; 94: 1567-1571
19. Dozois EJ, Boardman LA, Suwanthanma W, Limburg PJ, Cima RR, Bakken JL, Vierkant RA, Aakre JA, Larson DW. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome? Medicine (Baltimore) 2008; 87: 259-263
20. Clendenning M, Buchanan DD, Walsh MD, Nagler B, Rosty C, Thompson B, Spurdle AB, Hopper JL, Jenkins MA, Young JP. Mutation deep within an intron of MSH2 causes Lynch syndrome. Fam Cancer 2011; 10: 29
21. Limburg PJ, Harmsen WS, Chen HH, Gallinger S, Haile RW, Baron JA, Casey G, Woods MO, Thibodeau SN, Lindor NM. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clin Gastroenterol Hepatol 2011; 9: 497-502
22. Boardman LA, Morlan BW, Rabe KG, Petersen GM, Lindor NM, Nigon SK, Goldberg J, Gallinger S. Colorectal cancer risks in relatives of young-onset cases: is risk the same across all first-degree relatives? Clin Gastroenterol Hepatol 2007; 5: 1195-1198
23. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
24. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 2009; 18: 1695-1698
25. Platz EA, Giovannucci E, Rimm EB, Rockett HR, Stampfer MJ, Colditz GA, Willett WC. Dietary fiber and distal colorectal adenoma in men. Cancer Epidemiol Biomarkers Prev 1997; 6: 661-670
26. Tantamango YM, Knutsen SF, Beeson WL, Fraser G, Sabate J. Foods and food groups associated with the incidence of colorectal polyps: the Adventist Health Study. Nutr Cancer 2011; 63: 565-572
27. Soliman AS, Khorshid A, Ibrahim N, Dorgham L, McPherson RS. Diet and cooking practices in Egypt: Exploration of potential relationship to early-onset colorectal cancer. Nutr Res 1998; 18: 785-797
28. Galal OM. The nutrition transition in Egypt: obesity, undernutrition and the food consumption context. Public Health Nutr 2002; 5: 141-148
29. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003; 348: 883-890
30. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 348: 891-899
31. Benamouzig R, Deyra J, Martin A, Girard B, Jullian E, Piednoir B, Couturier D, Coste T, Little J, Chaussade S. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 2003; 125: 328-336
32. Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008; 134: 29-38
33. Sallam SA, Khallafallah NM, Ibrahim NK, Okasha AO. Pharmacoepidemiological study of self-medication in adults attending pharmacies in Alexandria, Egypt. East Mediterr Health J 2009; 15: 683-691
34. Scicluna EA, Borg MA, Gür D, Rasslan O, Taher I, Redjeb SB, Elnassar Z, Bagatzouni DP, Daoud Z. Self-medication with antibiotics in the ambulatory care setting within the Euro-Mediterranean region; results from the ARMed project. J Infect Public Health 2009; 2: 189-197
35. Kriegel AM, Soliman AS, Zhang Q, El-Ghawalby N, Ezzat F, Soultan A, Abdel-Wahab M, Fathy O, Ebidi G, Bassiouni N, Hamilton SR, Abbruzzese JL, Lacey MR, Blake DA. Serum cadmium levels in pancreatic cancer patients from the East Nile Delta region of Egypt. Environ Health Perspect 2006; 114: 113-119
36. Fedewa SA, Soliman AS, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Omar HG, Nriagu J, Wilson ML. Incidence analyses of bladder cancer in the Nile delta region of Egypt. Cancer Epidemiol 2009; 33: 176-181
37. Dey S, Soliman AS, Hablas A, Seifeldin IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD. Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Res Treat 2010; 120: 149-160
38. Uddin N, Fateem E, Hablas A, Seifeldin IA, Brown E, Merajver SD, Soliman AS. Public and professional educational needs for downstaging breast cancer in Egypt. J Cancer Educ 2012; 27: 149-155